Results for: expensive+drugs

Britain begins review to speed access to new drugs

Actavis to spend $66 billion on Allergan

'Possible' second Frenchman in IS execution video: prosecutor

AP IMPACT: 'Vaccine court' keeps claimants waiting

More meth labs showing up in cities, suburbs

Tea party lawmakers torn between beliefs, politics

Debate rages on over ECB bond-buying plan

Offenders get free pass on old arrest warrants

Health Net 4Q profit plummets as costs pile up

Pair avoids jail over drug importation from Bali

Insight: Some U.S. feedlots rue loss of 'Vitamin Z' Zilmax

AP IMPACT: Little restraint in military giveaways

London uses van with X-ray machine to find TB

Feds: All girls to have morning-after pill access

GSK distances itself from employees in China probe

Jackson's mother resumes testimony in LA courtroom

No Restrictions on Morning-After Pill, for Now

Cocaine bust derails fledgling GOP congressman

Toronto crack-smoking mayor off booze, and TV

Welfare changes move through NC General Assembly

Vietnamese hopeful of unproven Scientology 'detox'

Cameron Douglas' sentence is upheld in NY court

Pfizer 1Q profit up, but drugmaker cuts outlook

Study: Dementia tops cancer, heart disease in cost

Knox saga still not over for Italian courts

Masks galore: Japanese ward off pollen, pollution

Consequences of failure laid out in budget fight

US military expands its drug war in Latin America

Mistakenly freed killer captured while watching TV

Horsemeat: French company blamed, UK arrests

Cupid's Valentine helpers live in Miami airport

New drugs may make a dent in lung, ovarian cancer

Drop in Australian road deaths

Illegal profits: A look at insider trading

Day 5: Behind the scenes at the Cannes Film Festival

Roche's breast cancer drugs keep it on track to meet targets

Drug giant Ranbaxy's losses narrow despite sales dip

A look at South Carolina sheriffs in legal trouble

EU hits French drugmaker Servier with huge fine over generics

Police warning on bad batch of ecstasy

Great stadium, shame about the team in Brazil capital

Biotech stocks rout beginning to reveal pockets of value